Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram Yogev

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Allergy and Clinical Immunology|March 11, 2017
Long-term pulmonary complications in perinatally HIV-infected youthWilliam T Shearer, Denise L Jacobson, Wendy Yu, et al.
Bioanalysis|June 4, 2015
Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spotsDaniel Gonzalez, Chiara Melloni, Brenda B Poindexter, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and ChildrenJulie Autmizguine, Chiara Melloni, Christoph P Hornik, et al.
Journal of Clinical Pharmacology|April 21, 2018
Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in ChildrenChristoph P Hornik, Daniel Gonzalez, John van den Anker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 14, 2018
A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature dataSamantha H Dallefeld, Andrew M Atz, Ram Yogev, et al.
Brain, Behavior, and Immunity|January 17, 2017
Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognitionC Paula Lewis-de Los Angeles, Paige L Williams, Yanling Huo, et al.
The Pediatric Infectious Disease Journal|January 7, 2017
Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of AgeDaniel Gonzalez, John S Bradley, Jeffrey Blumer, et al.
Vaccine|October 10, 2013
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young childrenJanet A Englund, Ruth A Karron, Coleen K Cunningham, et al.
The Journal of Allergy and Clinical Immunology|November 12, 2003
Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 studyWilliam T Shearer, Howard M Rosenblatt, Rebecca S Gelman, et al.
Journal of Clinical Pharmacology|July 19, 2019
Population Pharmacokinetics of Milrinone in Infants, Children, and AdolescentsChristoph P Hornik, Ram Yogev, Peter M Mourani, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Allergy and Clinical Immunology|March 11, 2017
Long-term pulmonary complications in perinatally HIV-infected youthWilliam T Shearer, Denise L Jacobson, Wendy Yu, et al.
Bioanalysis|June 4, 2015
Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spotsDaniel Gonzalez, Chiara Melloni, Brenda B Poindexter, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and ChildrenJulie Autmizguine, Chiara Melloni, Christoph P Hornik, et al.
Journal of Clinical Pharmacology|April 21, 2018
Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in ChildrenChristoph P Hornik, Daniel Gonzalez, John van den Anker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 14, 2018
A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature dataSamantha H Dallefeld, Andrew M Atz, Ram Yogev, et al.
Brain, Behavior, and Immunity|January 17, 2017
Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognitionC Paula Lewis-de Los Angeles, Paige L Williams, Yanling Huo, et al.
The Pediatric Infectious Disease Journal|January 7, 2017
Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of AgeDaniel Gonzalez, John S Bradley, Jeffrey Blumer, et al.
Vaccine|October 10, 2013
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young childrenJanet A Englund, Ruth A Karron, Coleen K Cunningham, et al.
The Journal of Allergy and Clinical Immunology|November 12, 2003
Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 studyWilliam T Shearer, Howard M Rosenblatt, Rebecca S Gelman, et al.
Journal of Clinical Pharmacology|July 19, 2019
Population Pharmacokinetics of Milrinone in Infants, Children, and AdolescentsChristoph P Hornik, Ram Yogev, Peter M Mourani, et al.
Pageof 13